TYK MEDICINES-B (02410.HK) Stock Community - Hot Topic Discussions - Longbridge

Quote List Quote List

Event Tracking

Oct21

Three CDKi Drugs Early Clinical Trial Results of Tongyuankang Biopharma-B Presented at ESMO Annual Meeting

12:14

Aug31

TYK MEDICINES-B released FY2025 Q1 earnings on August 31, 2025 (BJT) with actual revenue of HKD 0 and EPS of HKD -0.1619

15:00

Tongyuankang Biopharma-B Announces 2025 H1 Results and R&D/Production Progress

10:46

TYK MEDICINES-B released FY2025 Semi-Annual Earnings on August 31 During-Market (BJT), with actual revenue HKD 0 and actual EPS HKD -0.3275

08:00

TYK MEDICINES-B released FY2025 Q2 earnings on August 31 During-Market BJT, actual revenue HKD 0, actual EPS HKD -0.1641

08:00

Aug23

TYK MEDICINES-B to Release FY2025 Semi-Annual Earnings on August 31, 2025 (BJT)

00:06

Schedules & Filings

Schedules

Filings

Aug31

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Net Income -61.39 M, EPS -0.1655

Mar27

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 56.92 K, Net Income -89.31 M, EPS -0.2516

Aug30

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Net Income -119.84 M, EPS -0.371

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More